Overview
Christopher Chen is a Hematologist in Palo Alto, California. Dr. Chen is highly rated in 9 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Stomach Cancer, and Lynch Syndrome.
His clinical research consists of co-authoring 41 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
875 Blake Wilbur Dr, Palo Alto, CA 94304
965 High St, Palo Alto, CA 94301
Additional Areas of Focus
Dr. Chen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Stanford University
Jason Gotlib is a Hematologist in Palo Alto, California. Dr. Gotlib is highly rated in 42 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy.
Lucile Packard Children's Hospital Stanford
Bertil Glader is a Hematologist in Palo Alto, California. Dr. Glader is highly rated in 23 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pyruvate Kinase Deficiency, Pure Red Cell Aplasia, Hemolytic Anemia, and Splenectomy.
Stanford Hospital And Clinics
David Miklos is a Hematologist in Stanford, California. Dr. Miklos is highly rated in 37 conditions, according to our data. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Christopher Chen
How do I make an appointment with Dr. Christopher Chen?
You can book an appointment with Dr. Christopher Chen by calling their office at 650-725-5421. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christopher Chen a top-rated expert for Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher Chen is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christopher Chen specialize in?
While Dr. Christopher Chen is a Hematology, they have specific expertise in Colorectal Cancer, Familial Colorectal Cancer, and Stomach Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Christopher Chen participate in research or clinical trials?
Yes. Dr. Christopher Chen has published 41 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Dr. Christopher Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christopher Chen accept my insurance?
Dr. Christopher Chen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 650-725-5421 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Chen isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Chen isDistinguished. Learn about Familial Colorectal Cancer.
- Stomach CancerDr. Chen isDistinguished. Learn about Stomach Cancer.
- Advanced
- Ampullary CancerDr. Chen isAdvanced. Learn about Ampullary Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Familial Pancreatic CancerDr. Chen isAdvanced. Learn about Familial Pancreatic Cancer.
- Gastroesophageal Junction Cancer
- Lynch SyndromeDr. Chen isAdvanced. Learn about Lynch Syndrome.
- Pancreatic CancerDr. Chen isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Adenoid Cystic CarcinomaDr. Chen isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Chen isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Chen isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Chen isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Chen isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer